FDA Inspection 1129519 — Scott R. Dobson MD
The FDA completed an inspection of Scott R. Dobson MD on August 21, 2020 in Greenville, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 21, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Greenville, SC (United States)
Additional Details
Clinical Investigator (CI)